This article is more than 5 years old. Information may no longer be current.

BoneSupport granted approval to market Cerament in India

Issue: April 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BoneSupport recently announced it has received regulatory approval from the Central Drugs Standards Control Organization and its Medical Device Approval Committee to market Cerament in India.
An injectable, antibiotic-eluting bone void filler/substitute, Cerament is indicated for both osteomyelitis management and the enhancement of bone healing threatened by infection. The company plans to work with regional distributors to make Cerament available to numerous hospital groups throughout India, according to a company press release.

“The Cerament platform has a long-standing safety profile, and we are pleased to see this once again confirmed by India’s approval,” Lloyd Diamond, CEO of BoneSupport, said in the release. “Cerament is an important advancement in the management of bone infections, and we are proud to be at the forefront in addressing an unmet need to patients in India.”

Reference: www.bonesupport.com.